Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The global antimicrobial resistance surveillance market is gaining increasing attention as the threat of drug-resistant infections poses serious challenges to public health. With advancements in technology and growing awareness about antibiotic misuse, this market is positioned for significant growth in the coming years. Below is an in-depth look at the market size, key growth drivers, main segments, evolving trends, leading companies, and regional developments shaping this industry.

Antimicrobial Resistance Surveillance Market Size and Growth Forecast

The antimicrobial resistance surveillance market has experienced notable expansion recently. It is projected to rise from $7.3 billion in 2025 to $7.91 billion in 2026, growing at a compound annual growth rate (CAGR) of 8.4%. This past growth period was driven by increasing occurrences of drug-resistant infections, enhanced hospital infection control measures, expansion of public health surveillance initiatives, broader laboratory testing capabilities, and heightened concerns over antibiotic misuse. Looking ahead, the market is expected to continue its strong upward trajectory, reaching $10.85 billion by 2030 at an 8.2% CAGR. Factors influencing growth during this forecast include global antimicrobial resistance (AMR) monitoring programs, the adoption of AI-powered predictive surveillance technologies, cloud-based platforms for data sharing, advancements in genomic surveillance, and regulatory mandates enforcing reporting. Emerging trends such as real-time monitoring of resistance patterns, whole genome sequencing, AI-driven resistance analytics, integrated public health databases, and hospital-wide AMR tracking systems are set to redefine the market landscape.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21100&type=smp

Rising Infectious Disease Rates as a Key Growth Catalyst

One of the primary forces propelling the expansion of the antimicrobial resistance surveillance market is the increasing prevalence of infectious diseases. These illnesses, caused by bacteria, viruses, fungi, or parasites, can be transmitted through various direct or indirect means. The surge in infectious diseases is influenced by factors including climate change, urbanization, and global travel, all of which facilitate the spread of pathogens and increase human exposure to unfamiliar microbes. Antimicrobial resistance surveillance plays a vital role in monitoring the dissemination of resistant strains, thus helping guide effective treatments and public health interventions. For example, a report released in February 2024 by the UK Health Security Agency showed a 10.7% rise in tuberculosis (TB) cases in England during 2023, with 4,850 cases compared to 4,380 in 2022. This example highlights how infectious disease trends are driving demand for improved AMR surveillance systems.

Additional Drivers Supporting Market Expansion

Beyond infectious disease prevalence, several other elements support the growth of the antimicrobial resistance surveillance market. Increased investments in hospital infection control protocols aim to prevent the spread of resistant pathogens within healthcare settings. Moreover, growing public health initiatives emphasize surveillance programs that track antibiotic resistance patterns on a broader scale. Expansion of laboratory testing facilities and technological advancements are enhancing the accuracy and speed of resistance detection. Finally, rising global concerns regarding the misuse and overuse of antibiotics have prompted governments and health organizations to prioritize resistance monitoring efforts, boosting market demand.

https://www.thebusinessresearchcompany.com/report/antimicrobial-resistance-surveillance-global-market-report

Antimicrobial Resistance Surveillance Market Geographic Analysis: Where Is Demand Growing The Fastest?

Segmentation Overview of the Antimicrobial Resistance Surveillance Market

This market is segmented based on solutions, applications, and end users. The solution segment includes diagnostic kits, diagnostic systems, surveillance software, and services. Diagnostic kits are further divided into PCR-based kits, immunoassay kits, and lateral flow assay kits. Diagnostic systems cover automated susceptibility testing systems, whole genome sequencing (WGS) systems, and mass spectrometry-based systems. Surveillance software comprises cloud-based platforms, AI-powered analytics tools, and electronic health record (EHR)-integrated systems. Services include laboratory testing, data management and reporting, as well as consultation and training. Application areas include clinical diagnostics, public health surveillance, and other uses. The end-user base encompasses hospitals and clinics, research and academic institutions, and other users.

How Technological Advances Are Transforming the Market

Market players are increasingly focusing on cutting-edge diagnostic tools designed to improve efficiency, accuracy, and patient outcomes while reducing costs. Diagnostic tools refer broadly to devices, instruments, software, or methods used to detect or assess health conditions or pathogens. For instance, in June 2023, Sweden-based Sysmex Astrego AB introduced the PA-100 AST Point-of-Care Testing System. This innovative device enables rapid and precise detection of antimicrobial resistance directly at the point of care, delivering results within 30 minutes—a significant improvement over traditional lab methods that can take several days. Such technology allows clinicians to make timely treatment decisions, minimizing the use of broad-spectrum antibiotics and helping to curb the spread of resistance.

Leading Companies Driving Competition in the Antimicrobial Resistance Surveillance Market

Key players shaping the competitive landscape include Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Cepheid Inc., Accelerate Diagnostics Inc., Liofilchem S.r.l., Luminex Corporation, Sysmex Corporation, Werfen, OpGen Inc., Illumina Inc., Oxford Nanopore Technologies plc, Himedia Laboratories Pvt. Ltd., and Alifax S.r.l. These companies are actively investing in research and development to bring innovative products and solutions to the market.

Regional Market Dynamics and Growth Hotspots

In 2025, North America held the largest share of the antimicrobial resistance surveillance market, reflecting the region’s strong healthcare infrastructure and investment capacity. However, the Asia-Pacific region is forecasted to experience the fastest growth during the upcoming years, driven by rising infectious disease prevalence, expanding healthcare facilities, and increasing adoption of advanced technologies. The market report also encompasses regions such as South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, giving a comprehensive view of global market trends and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model